| 000 | 01874 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515015845.0 | ||
| 264 | 0 | _c20060509 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a0022-3492 | ||
| 024 | 7 |
_a10.1902/jop.2006.050016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLan, Jing | |
| 245 | 0 | 0 |
_aThe effect of combination of recombinant human bone morphogenetic protein-2 and basic fibroblast growth factor or insulin-like growth factor-I on dental implant osseointegration by confocal laser scanning microscopy. _h[electronic resource] |
| 260 |
_bJournal of periodontology _cMar 2006 |
||
| 300 |
_a357-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBone Morphogenetic Protein 2 |
| 650 | 0 | 4 |
_aBone Morphogenetic Proteins _xpharmacology |
| 650 | 0 | 4 | _aCoated Materials, Biocompatible |
| 650 | 0 | 4 | _aDental Implantation, Endosseous |
| 650 | 0 | 4 | _aDental Implants |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemur |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImplants, Experimental |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xpharmacology |
| 650 | 0 | 4 | _aLactic Acid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicroscopy, Confocal |
| 650 | 0 | 4 |
_aOsseointegration _xdrug effects |
| 650 | 0 | 4 | _aPolyesters |
| 650 | 0 | 4 | _aPolymers |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xpharmacology |
| 700 | 1 | _aWang, Zhifeng | |
| 700 | 1 | _aWang, Yining | |
| 700 | 1 | _aWang, Jiawei | |
| 700 | 1 | _aCheng, Xiangrong | |
| 773 | 0 |
_tJournal of periodontology _gvol. 77 _gno. 3 _gp. 357-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1902/jop.2006.050016 _zAvailable from publisher's website |
| 999 |
_c16122942 _d16122942 |
||